# Modified Ketogenic Diet and Ketamine for Anorexia Nervosa

> **NCT04714541** · PHASE1 · COMPLETED · sponsor: **Homeostasis Therapeutics, LLC** · enrollment: 5 (actual)

## Conditions studied

- Anorexia Nervosa

## Interventions

- **DRUG:** Ketamine Hcl 50Mg/Ml Inj

## Key facts

- **NCT ID:** NCT04714541
- **Lead sponsor:** Homeostasis Therapeutics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-12
- **Primary completion:** 2022-07-26
- **Final completion:** 2022-07-26
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04714541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04714541, "Modified Ketogenic Diet and Ketamine for Anorexia Nervosa". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04714541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*